<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Tan TG</submitter><funding>Intramural NIH HHS</funding><funding>NIAID NIH HHS</funding><pagination>3977-89</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC2895808</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>28(23)</volume><pubmed_abstract>Toxoplasma gondii is an intracellular parasite that causes severe neurologic and ocular disease in immune-compromised and congenitally infected individuals. There is no vaccine protective against human toxoplasmosis. Herein, immunization of L(d) mice with HF10 (HPGSVNEFDF) with palmitic acid moieties or a monophosphoryl lipid A derivative elicited potent IFN-gamma production from L(d)-restricted CD8(+) T cells in vitro and protected mice. CD8(+) T cell peptide epitopes from T. gondii dense granule proteins GRA 3, 6, 7, and Sag 1, immunogenic in humans for HLA-A02(+), HLA-A03(+), and HLA-B07(+) cells were identified. Since peptide repertoire presented by MHC class I molecules to CD8(+) T cells is shaped by endoplasmic reticulum-associated aminopeptidase (ERAAP), polymorphisms in the human E</pubmed_abstract><journal>Vaccine</journal><pubmed_title>Identification of T. gondii epitopes, adjuvants, and host genetic factors that influence protection of mice and humans.</pubmed_title><pmcid>PMC2895808</pmcid><funding_grant_id>R01 AI027530</funding_grant_id><funding_grant_id>R01 AI071319</funding_grant_id><funding_grant_id>U01 AI77887</funding_grant_id><funding_grant_id>U01 AI077887</funding_grant_id><pubmed_authors>McLeod R</pubmed_authors><pubmed_authors>Tan TG</pubmed_authors><pubmed_authors>Sette A</pubmed_authors><pubmed_authors>Mui E</pubmed_authors><pubmed_authors>Witola WH</pubmed_authors><pubmed_authors>Cong H</pubmed_authors><pubmed_authors>Maewal A</pubmed_authors><pubmed_authors>Montpetit A</pubmed_authors><pubmed_authors>Muench SP</pubmed_authors><pubmed_authors>Grigg ME</pubmed_authors><pubmed_authors>Sidney J</pubmed_authors><pubmed_authors>Alexander J</pubmed_authors></additional><is_claimable>false</is_claimable><name>Identification of T. gondii epitopes, adjuvants, and host genetic factors that influence protection of mice and humans.</name><description>Toxoplasma gondii is an intracellular parasite that causes severe neurologic and ocular disease in immune-compromised and congenitally infected individuals. There is no vaccine protective against human toxoplasmosis. Herein, immunization of L(d) mice with HF10 (HPGSVNEFDF) with palmitic acid moieties or a monophosphoryl lipid A derivative elicited potent IFN-gamma production from L(d)-restricted CD8(+) T cells in vitro and protected mice. CD8(+) T cell peptide epitopes from T. gondii dense granule proteins GRA 3, 6, 7, and Sag 1, immunogenic in humans for HLA-A02(+), HLA-A03(+), and HLA-B07(+) cells were identified. Since peptide repertoire presented by MHC class I molecules to CD8(+) T cells is shaped by endoplasmic reticulum-associated aminopeptidase (ERAAP), polymorphisms in the human E</description><dates><release>2010-01-01T00:00:00Z</release><publication>2010 May</publication><modification>2026-04-16T21:21:49.22Z</modification><creation>2026-04-07T14:17:43.879Z</creation></dates><accession>S-EPMC2895808</accession><cross_references><pubmed>20347630</pubmed><doi>10.1016/j.vaccine.2010.03.028</doi></cross_references></HashMap>